Symptom management in MS remains a very important determinant of quality of life in MS patients, even with the advent of increasing numbers of MS disease-modifying therapies. Symptoms of MS may be under-recognized and there are knowledge gaps among neurologists regarding management of these common symptoms. Faculty will review the management of common MS symptoms including spasticity, fatigue, gait disorders, bladder problems, bowel problems, and sexual dysfunction, and conclude with a panel discussion regarding management of these and other commonly encountered symptoms in MS patients.
This program complements C36: Multiple Sclerosis Therapy: Disease-modifying Treatment I and C54: Multiple Sclerosis Therapy: Disease-modifying Treatment II, but covers independent topics.
Participants should be able to diagnose and treat symptoms of fatigue, sleep disorders, spasticity, gait difficulties, bladder and bowel symptoms, and sexual dysfunction in MS patients.
Medical Knowledge, Patient Care
Program Speakers - Tentative
7:00 AM - 7:30 AM
Management of Fatigue, Sleep Disorders, and Spasticity in MS
Jonathan L. Carter MD
7:30 AM - 8:00 AM
Management of Ambulatory Dysfunction in MS
Michelle Cameron MD
8:00 AM - 8:30 AM
Management of GU Dysfunction: When MS Hits Below the Belt
Barbara S. Giesser MD, FAAN
8:30 AM - 9:00 AM
Case-Based Panel Discussion: MS Symptom Management
Michelle Cameron, MD
Dr. Cameron has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Adamas Corporation. Dr. Cameron has received personal compensation in an editorial capacity for Current Neurology and Neuroscience Reports.
Jonathan L. Carter, MD
Dr. Carter received personal compensation from Alder Pharmaceuticals Inc., for serving as a member of a Data Safety Monitoring Committee for a migraine clinical trial. Dr. Carter received personal compensation from the Global Academy for Medical Education for CME activities as a course co-director and speaker for the Summit in Neurology and Psychiatry CME course, and for preparing a MS Drug Monograph for Omnicare, Inc. Dr. Carter has received research support from Sanofi, Genzyme, and Roche.